 | • レポートコード：D0GIR-01619 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、化学療法による吐き気・嘔吐（CINV）の世界市場を広く調査・分析し、今後の市場展望をまとめております。化学療法による吐き気・嘔吐（CINV）の種類別市場規模（CINV、PONV）、用途別市場規模（病院、外来手術センター、診断センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、Novartis、Helsinn Holding、Eisai、Teva、ProStrakan、Roche、Qilu Pharma、Mundipharma、Heron Therapeutics、Mylan、Tesaro ・地域別グローバル市場分析 2015年-2020年 ・化学療法による吐き気・嘔吐（CINV）の北米市場（アメリカ、カナダ、メキシコ） ・化学療法による吐き気・嘔吐（CINV）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・化学療法による吐き気・嘔吐（CINV）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・化学療法による吐き気・嘔吐（CINV）の南米市場（ブラジル、アルゼンチン） ・化学療法による吐き気・嘔吐（CINV）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：CINV、PONV ・用途別分析：病院、外来手術センター、診断センター ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Chemotherapy-Induced Nausea and Vomiting (CINV) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Chemotherapy-Induced Nausea and Vomiting (CINV) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Chemotherapy-Induced Nausea and Vomiting (CINV) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Chemotherapy-Induced Nausea and Vomiting (CINV) market has been segmented into:
CINV
PONV
By Application, Chemotherapy-Induced Nausea and Vomiting (CINV) has been segmented into:
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Chemotherapy-Induced Nausea and Vomiting (CINV) market presented in the report. This section sheds light on the sales growth of different regional and country-level Chemotherapy-Induced Nausea and Vomiting (CINV) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Chemotherapy-Induced Nausea and Vomiting (CINV) market.
The report offers in-depth assessment of the growth and other aspects of the Chemotherapy-Induced Nausea and Vomiting (CINV) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share Analysis
Chemotherapy-Induced Nausea and Vomiting (CINV) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Chemotherapy-Induced Nausea and Vomiting (CINV) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Chemotherapy-Induced Nausea and Vomiting (CINV) sales, revenue and market share for each player covered in this report.
The major players covered in Chemotherapy-Induced Nausea and Vomiting (CINV) are:
Merck
Novartis
Helsinn Holding
Eisai
Teva
ProStrakan
Roche
Qilu Pharma
Mundipharma
Heron Therapeutics
Mylan
Tesaro
Table of Contents
1 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview
1.1 Product Overview and Scope of Chemotherapy-Induced Nausea and Vomiting (CINV)
1.2 Classification of Chemotherapy-Induced Nausea and Vomiting (CINV) by Type
1.2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Type in 2019
1.2.3 CINV
1.2.4 PONV
1.3 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market by Application
1.3.1 Overview: Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market by Regions
1.4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Chemotherapy-Induced Nausea and Vomiting (CINV) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Chemotherapy-Induced Nausea and Vomiting (CINV) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Chemotherapy-Induced Nausea and Vomiting (CINV) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chemotherapy-Induced Nausea and Vomiting (CINV) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Chemotherapy-Induced Nausea and Vomiting (CINV) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chemotherapy-Induced Nausea and Vomiting (CINV) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Helsinn Holding
2.3.1 Helsinn Holding Details
2.3.2 Helsinn Holding Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Helsinn Holding SWOT Analysis
2.3.4 Helsinn Holding Product and Services
2.3.5 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eisai
2.4.1 Eisai Details
2.4.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eisai SWOT Analysis
2.4.4 Eisai Product and Services
2.4.5 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Teva
2.5.1 Teva Details
2.5.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Teva SWOT Analysis
2.5.4 Teva Product and Services
2.5.5 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2018-2019)
2.6 ProStrakan
2.6.1 ProStrakan Details
2.6.2 ProStrakan Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 ProStrakan SWOT Analysis
2.6.4 ProStrakan Product and Services
2.6.5 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Roche SWOT Analysis
2.7.4 Roche Product and Services
2.7.5 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2018-2019)
2.8 Qilu Pharma
2.8.1 Qilu Pharma Details
2.8.2 Qilu Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Qilu Pharma SWOT Analysis
2.8.4 Qilu Pharma Product and Services
2.8.5 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2018-2019)
2.9 Mundipharma
2.9.1 Mundipharma Details
2.9.2 Mundipharma Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Mundipharma SWOT Analysis
2.9.4 Mundipharma Product and Services
2.9.5 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2018-2019)
2.10 Heron Therapeutics
2.10.1 Heron Therapeutics Details
2.10.2 Heron Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Heron Therapeutics SWOT Analysis
2.10.4 Heron Therapeutics Product and Services
2.10.5 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2018-2019)
2.11 Mylan
2.11.1 Mylan Details
2.11.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Mylan SWOT Analysis
2.11.4 Mylan Product and Services
2.11.5 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2018-2019)
2.12 Tesaro
2.12.1 Tesaro Details
2.12.2 Tesaro Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Tesaro SWOT Analysis
2.12.4 Tesaro Product and Services
2.12.5 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Chemotherapy-Induced Nausea and Vomiting (CINV) Players Market Share
3.2.2 Top 10 Chemotherapy-Induced Nausea and Vomiting (CINV) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Market Share by Regions
4.2 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
4.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
4.5 South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
5 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries
5.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2015-2020)
5.2 USA Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
5.3 Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
5.4 Mexico Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
6 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries
6.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2015-2020)
6.2 Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
6.3 UK Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
6.4 France Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
6.5 Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
6.6 Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries
7.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2015-2020)
7.2 China Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
7.3 Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
7.4 Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
7.5 India Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
8 South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries
8.1 South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2015-2020)
8.2 Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
8.3 Argentina Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Chemotherapy-Induced Nausea and Vomiting (CINV) by Countries
9.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
9.3 UAE Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
9.4 Egypt Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
9.5 South Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Market Share by Type (2015-2020)
10.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Forecast by Type (2019-2024)
10.3 CINV Revenue Growth Rate (2015-2025)
10.4 PONV Revenue Growth Rate (2015-2025)
11 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Segment by Application
11.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Application (2015-2020)
11.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.5 Diagnostic Centers Revenue Growth (2015-2020)
12 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Forecast (2021-2025)
12.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Forecast (2021-2025)
12.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Forecast by Regions (2021-2025)
12.3 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2021-2025)
12.4 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2021-2025)
12.6 South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Chemotherapy-Induced Nausea and Vomiting (CINV) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Merck Corporate Information, Location and Competitors
Table 6. Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Major Business
Table 7. Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Total Revenue (USD Million) (2017-2018)
Table 8. Merck SWOT Analysis
Table 9. Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Solutions
Table 10. Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Novartis Corporate Information, Location and Competitors
Table 12. Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Major Business
Table 13. Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Total Revenue (USD Million) (2018-2019)
Table 14. Novartis SWOT Analysis
Table 15. Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Solutions
Table 16. Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Helsinn Holding Corporate Information, Location and Competitors
Table 18. Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Major Business
Table 19. Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Total Revenue (USD Million) (2017-2018)
Table 20. Helsinn Holding SWOT Analysis
Table 21. Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Solutions
Table 22. Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Eisai Corporate Information, Location and Competitors
Table 24. Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Major Business
Table 25. Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Total Revenue (USD Million) (2017-2018)
Table 26. Eisai SWOT Analysis
Table 27. Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Solutions
Table 28. Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Teva Corporate Information, Location and Competitors
Table 30. Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Major Business
Table 31. Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Total Revenue (USD Million) (2017-2018)
Table 32. Teva SWOT Analysis
Table 33. Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Solutions
Table 34. Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. ProStrakan Corporate Information, Location and Competitors
Table 36. ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Major Business
Table 37. ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Total Revenue (USD Million) (2017-2018)
Table 38. ProStrakan SWOT Analysis
Table 39. ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Solutions
Table 40. ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Roche Corporate Information, Location and Competitors
Table 42. Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Major Business
Table 43. Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Total Revenue (USD Million) (2017-2018)
Table 44. Roche SWOT Analysis
Table 45. Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Solutions
Table 46. Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Qilu Pharma Corporate Information, Location and Competitors
Table 48. Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Major Business
Table 49. Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Total Revenue (USD Million) (2017-2018)
Table 50. Qilu Pharma SWOT Analysis
Table 51. Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Solutions
Table 52. Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Mundipharma Corporate Information, Location and Competitors
Table 54. Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Major Business
Table 55. Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Total Revenue (USD Million) (2017-2018)
Table 56. Mundipharma SWOT Analysis
Table 57. Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Solutions
Table 58. Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Heron Therapeutics Corporate Information, Location and Competitors
Table 60. Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Major Business
Table 61. Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Total Revenue (USD Million) (2017-2018)
Table 62. Heron Therapeutics SWOT Analysis
Table 63. Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Solutions
Table 64. Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Mylan Corporate Information, Location and Competitors
Table 66. Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Major Business
Table 67. Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Total Revenue (USD Million) (2017-2018)
Table 68. Mylan SWOT Analysis
Table 69. Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Solutions
Table 70. Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Tesaro Corporate Information, Location and Competitors
Table 72. Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Major Business
Table 73. Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Total Revenue (USD Million) (2017-2018)
Table 74. Tesaro SWOT Analysis
Table 75. Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Solutions
Table 76. Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Players (2015-2020)
Table 78. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Players (2015-2020)
Table 79. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Regions (2015-2020)
Table 81. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2015-2020)
Table 82. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2015-2020)
Table 83. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2015-2020)
Table 86. South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2015-2020)
Table 89. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Type (2015-2020)
Table 90. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Type (2015-2020)
Table 91. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Forecast by Type (2021-2025)
Table 92. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Application (2015-2020)
Table 93. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Application (2015-2020)
Table 94. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Forecast by Application (2021-2025)
Table 95. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Chemotherapy-Induced Nausea and Vomiting (CINV) Picture
Figure 2. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Type in 2019
Figure 3. CINV Picture
Figure 4. PONV Picture
Figure 5. Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Ambulatory Surgical Centers Picture
Figure 8. Diagnostic Centers Picture
Figure 9. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share in 2019
Figure 18. Global Top 10 Players Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Regions (2015-2020)
Figure 22. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Regions in 2018
Figure 23. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 24. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 26. South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 28. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2015-2020)
Figure 29. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries in 2019
Figure 30. USA Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 31. Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 33. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries in 2019
Figure 35. Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 36. UK Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 37. France Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 38. Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 39. Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries in 2019
Figure 42. China Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 43. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 44. Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 45. India Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 47. South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2015-2020)
Figure 48. South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries in 2019
Figure 49. Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 54. UAE Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2015-2020)
Figure 57. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Type (2015-2020)
Figure 58. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Type in 2019
Figure 59. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share Forecast by Type (2021-2025)
Figure 60. Global CINV Revenue Growth Rate (2015-2020)
Figure 61. Global PONV Revenue Growth Rate (2015-2020)
Figure 62. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Application (2015-2020)
Figure 63. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Application in 2019
Figure 64. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 66. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 67. Global Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 68. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2021-2025)
Figure 72. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2021-2025)
Figure 74. South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
術後悪心嘔吐（PONV）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Postoperative Nausea and Vomiting (PONV) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Post…- 化学療法誘発性貧血（CIA）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Chemotherapy Induced Anemia market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chemotherapy Indu…
- 電界誘起高分子エレクトロルミネセンス（FIPEL）製品・技術の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Field-Induced Polymer Electroluminescent (FIPEL) Products and Technology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from …
- オピオイド誘発性便秘治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Opioid Induced Constipation Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 16.9% in the forecast period of 2020 to 2025 and will expected to reach USD 1888.6 million by 2025, from USD 1010.3 million in 2019. T…
- ヘパリン誘発性血小板減少症（HIT）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Heparin-Induced Thrombocytopenia (HIT) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players…